Omics Data Science Core boosts bioinformatics support for immune research
Official title: Omics Data Science Core (ODSC)
Funded at University of Oklahoma · NIH-11269425 · Data updated 2026-11-12
A new Omics Data Science Core in Oklahoma helps researchers analyze multi-omics data to better understand the human immune system and guide immunoengineering work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project start | May 15, 2026 |
| Project end | January 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $373,195 |
| NIH project number | 1P20GM162339-01 |
| Project ID | NIH-11269425 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and clinicians in Oklahoma and IDeA states conducting immunology or immunoengineering projects who need bioinformatics and data-science support.
✕Less likely to help
Direct patient participation is not described; the grant focuses on building infrastructure and services for researchers.
What this research studies
The Omics Data Science Core (ODSC) will provide end-to-end bioinformatics services for multi-omics studies, helping researchers design experiments, process data, and interpret results for publications and grants. It will offer regular training on new omics methods and data-science techniques, and build a collaborative user community. The core aims to establish a dedicated team, create the necessary computational infrastructure, and deliver project-based support to immunoengineering researchers in Oklahoma and other IDeA states.
Why it matters
Potential benefit: If successful, patients could benefit from faster translation of immunoengineering research into therapies and improved understanding of immune responses.
How similar studies have gone: Bioinformatics cores and data-science centers have shown value in accelerating omics analyses and grant submissions in related institutions.
Where this research is happening
-
University of Oklahoma
Norman, United States Active
Researchers
- Principal investigator: Pan, Chongle — University of Oklahoma
- Study coordinator: Pan, Chongle
Related research
Other NIH-funded projects on the same topics.
-
Personalized 3D molds to shape breast reconstruction
A doctor-relevant project is testing patient-specific 3D printed molds to guide breast reconstruction after mastectomy, aiming to improve body image and quality of life for feminine-presenting individuals.
-
Faster 3D/4D imaging to speed up testing of cancer drugs on tumor organoids
This project builds a new, ultrafast label-free 4D imaging system with AI to watch how patient-like tumor organoids respond to cancer drugs, helping researchers find more promising treatments.
-
How our genes control skin color and pigmentation
Scientists are studying how epigenetic and transcriptional controls shape human skin color and related pigmentation differences.
-
Nanomedicine delivery framework for skeletal muscle therapies
A new framework aims to safely and efficiently deliver tiny nanoparticles carrying drugs or genetic payloads to skeletal muscle cells.
-
Atlas of bacterial drug entry and exit to help design better antibiotics
Researchers are building smart computer models and chemical tests to understand how to get drugs into Gram-negative bacteria like Acinetobacter baumannii so new antibiotics can work.
-
Understanding protein forms in disease with advanced mass spectrometry
A researchers team will use a cutting-edge mass spectrometry approach to map and measure the full shape and connections of disease-related proteins in human biology.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.